Search for new products by date added, alphabetically, or by pharmacological action.
New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules and peptides being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can. New products can be identified throughout the Tocris website by the New symbol.
If you can't find what you are looking for we welcome new product suggestions. If you would like to be kept informed about new products by email, please sign up for our monthly e-alert service.
5-HT1A Receptors | ||
| Cat No | Product Name / Activity | Date Added |
|---|---|---|
| 6202 | Vilazodone hydrochloride | Apr 2017 |
| Potent 5-HT1A partial agonist and SSRI; antidepressant | ||
Ack1 | ||
| Cat No | Product Name / Activity | Date Added |
| 6061 | XMD 8-87 | May 2017 |
| Potent Ack1/TNK2 inhibitor | ||
Actin | ||
| Cat No | Product Name / Activity | Date Added |
| 3974 | Latrunculin B | May 2017 |
| Inhibitor of actin polymerization | ||
Adenylyl Cyclases | ||
| Cat No | Product Name / Activity | Date Added |
| 6271 | ST 034307 | May 2017 |
| Adenylyl cyclase 1 (AC1) inhibitor; analgesic and active in vivo | ||
Adrenergic β2 Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6219 | Arformoterol tartrate | Apr 2017 |
| Long-acting β2 agonist (LABA) | ||
AMPA Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6278 | JNJ 55511118 | Aug 2017 |
| Selective, high affinity negative modulator of AMPA receptors containing TARP-γ8 | ||
Androgen Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6161 | Ailanthone | Apr 2017 |
| Potent inhibitor of androgen receptor (AR) | ||
Antibiotics | ||
| Cat No | Product Name / Activity | Date Added |
| 6250 | Filipin III | Mar 2017 |
| Polyene antibiotic; inhibits formation of pathological isoform of prion protein | ||
Antivirals | ||
| Cat No | Product Name / Activity | Date Added |
| 5741 | 25-Hydroxycholesterol | Apr 2017 |
| Antiviral; also α-crystallin (cryAB) chaperone | ||
| 6045 | NITD 008 | Jul 2017 |
| Antiviral; selective flavivirus inhibitor | ||
| 6183 | Nanchangmycin | May 2017 |
| Antiviral; active against Zika, West Nile and dengue viruses | ||
Apelin Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6294 | ELA-14 negative control | Jun 2017 |
| Negative control for ELA-14 (Cat.No.6293). | ||
| 6293 | ELA-14 (human) | Jun 2017 |
| Potent apelin (APJ) receptor agonist | ||
| 6292 | ELARR>GG | Jul 2017 |
| Negative control for ELA-32 (Cat.No.6291). | ||
| 6291 | ELA-32 (human) | Jul 2017 |
| Potent, high affinity apelin receptor agonist; stimulates angiogenesis | ||
Biochemicals and Molecular Biology | ||
| Cat No | Product Name / Activity | Date Added |
| 5407 | GA3-AM | Mar 2017 |
| Gibberellin-analog (GA3) chemical dimerizer; cell permeable | ||
| 6175 | DBHDA | Apr 2017 |
| Reagent for synthetic biology; converts cysteine to dehydroalanine | ||
| 6146 | LAP | Mar 2017 |
| Photocrosslinker for hydrogels | ||
| 6253 | F 127 (20% solution in DMSO) | Apr 2017 |
| Nonionic detergent | ||
BMP and Other Activin Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6151 | LDN 212854 | Apr 2017 |
| Potent bone morphogenetic protein type I (ALK) inhibitor | ||
| 6152 | LDN 214117 | Apr 2017 |
| Potent and selective ALK2 inhibitor | ||
Bradykinin Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6190 | Retrobradykinin | Apr 2017 |
| Reverse analog of Bradykinin | ||
Bromodomains | ||
| Cat No | Product Name / Activity | Date Added |
| 6105 | TC AC 28 | Mar 2017 |
| High affinity BET bromodomain ligand | ||
| 6181 | OTX 015 | May 2017 |
| BET bromodomain inhibitor; orally bioavailable | ||
Buffers, Solvents and Solutions | ||
| Cat No | Product Name / Activity | Date Added |
| 5888 | MOPSO, free acid | May 2017 |
| Buffer; working pH range in aqueous solution: 6.2-7.6 | ||
| 5873 | CAPS | Feb 2017 |
| Buffer widely used in Western blotting | ||
| 5881 | Bicine | Feb 2017 |
| General purpose buffer | ||
| 5879 | ACES | Feb 2017 |
| Zwitterionic buffer | ||
Caged Compounds | ||
| Cat No | Product Name / Activity | Date Added |
| 6210 | ci-IP3/PM | Mar 2017 |
| Caged inositol triphosphate | ||
| 6121 | NB-caged Tyrosine hydrochloride | May 2017 |
| ortho-nitrobenzyl caged L- tyrosine | ||
Calcium-Sensing Receptor | ||
| Cat No | Product Name / Activity | Date Added |
| 6165 | AC 265347 | Jul 2017 |
| CaSR biased allosteric modulator | ||
| 6170 | Cinacalcet hydrochloride | Feb 2017 |
| Calcium-sensing receptor (CaSR) allosteric agonist; also CYP2D2 inhibitor and Ca2+ channel blocker; orally bioavailable | ||
CB1 Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6193 | AM 4113 | Aug 2017 |
| Selective, high affinity CB1 antagonist | ||
CB2 Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 5826 | LEI 101 hydrochloride | May 2017 |
| Potent and selective CB2 partial agonist; orally biovailable | ||
Cdc2-like Kinases | ||
| Cat No | Product Name / Activity | Date Added |
| 5700 | ML 315 hydrochloride | Apr 2017 |
| Inhibitor of Clk and DYRK kinases | ||
Chemokine CXC Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 5872 | AZ 10397767 | Mar 2017 |
| Potent CXCR2 antagonist | ||
Cyclin-Dependent Protein Kinases | ||
| Cat No | Product Name / Activity | Date Added |
| 6174 | CVT 313 | Jun 2017 |
| cdk2 inhibitor | ||
Cytochrome P450 | ||
| Cat No | Product Name / Activity | Date Added |
| 6204 | 7-Ethoxyresorufin | Mar 2017 |
| Fluorometric CYP450 substrate | ||
Cytokine Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 5372 | Bioymifi | May 2017 |
| DR5 (TRAIL receptor) agonist; induces apoptosis | ||
Cytokines | ||
| Cat No | Product Name / Activity | Date Added |
| 6107 | CP 424174 | Mar 2017 |
| Inhibitor of IL-1β post-translational processing; indirectly inhibits NLRP3 | ||
D2 Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6171 | MLS 1547 | Mar 2017 |
| G protein-biased D2 receptor partial agonist | ||
Death-Associated Protein Kinase | ||
| Cat No | Product Name / Activity | Date Added |
| 5768 | HS 38 | Jul 2017 |
| ATP-competitive inhibitor of DAPK and ZIPK | ||
Dihydrofolate Reductase | ||
| Cat No | Product Name / Activity | Date Added |
| 6185 | Pemetrexed | Jun 2017 |
| High affinity dihydrofolate reductase inhibitor; also inhibits thymidylate synthase, GARFT and AICART | ||
DNA, RNA and Protein Synthesis | ||
| Cat No | Product Name / Activity | Date Added |
| 5419 | PCNA I1 | Feb 2017 |
| PCNA inhibitor | ||
| 6168 | RI 1 | Apr 2017 |
| RAD51 recombinase inhibitor | ||
EGFR | ||
| Cat No | Product Name / Activity | Date Added |
| 6231 | Dacomitinib | Jul 2017 |
| Potent irreversible pan ErbB inhibitor | ||
Enzyme Substrates / Activators | ||
| Cat No | Product Name / Activity | Date Added |
| 6213 | H3K27(Me3) (15-34) | Apr 2017 |
| Histone H3 peptide; substrate for methyltransferase/demethylase enzymes | ||
| 6212 | H3K27(Me2) (15-34) | Apr 2017 |
| Histone H3 peptide; substrate for methyltransferase/demethylase enzymes | ||
| 6217 | Histone H3 (1-34) | Apr 2017 |
| Histone H3 peptide | ||
| 6216 | H3K4(Me3) (1-20) | Apr 2017 |
| Histone H3 peptide; substrate for methyltransferase/demethylase enzymes | ||
| 6214 | H3K4(Me) (1-20) | Apr 2017 |
| Histone H3 peptide; substrate for methyltransferase/demethylase enzymes | ||
| 6211 | H3K27(Me) (15-34) | Apr 2017 |
| Histone H3 peptide; substrate for demethylase/methyltransferase enzymes | ||
Estrogen (GPER) Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6116 | BHPI | Aug 2017 |
| ERα antagonist; also activates unfolded protein response; active in vivo | ||
Estrogen and Related Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6158 | (S)-Equol | May 2017 |
| Potent estrogen receptor β (ERβ) agonist; dihydrotestosterone antagonist | ||
Fluorescent Dyes | ||
| Cat No | Product Name / Activity | Date Added |
| 5437 | Cyanine 7, SE | Mar 2017 |
| Near-infrared fluorescent dye for labeling of amines | ||
| 5435 | Cyanine 3, SE | Mar 2017 |
| Orange fluorescent dye for labeling of amines | ||
| 6149 | PA Janelia Fluor® 549, SE | Apr 2017 |
| Photoactivatable cell permeable fluorescent dye; supplied as NHS ester | ||
| 6150 | PA Janelia Fluor® 646, SE | Apr 2017 |
| Photoactivatable cell permeable fluorescent dye; supplied as NHS ester | ||
Gap Channels | ||
| Cat No | Product Name / Activity | Date Added |
| 6227 | TAT-Gap19 | Apr 2017 |
| Cx43 hemichannel blocker | ||
General Calcium Signaling Agents | ||
| Cat No | Product Name / Activity | Date Added |
| 5976 | Ned K | Apr 2017 |
| NAADP signaling inhibitor | ||
Glucose Transporters | ||
| Cat No | Product Name / Activity | Date Added |
| 6100 | Fasentin | May 2017 |
| GLUT1/GLUT4 inhibitor; also Fas-sensitizer | ||
Glycogen Synthase Kinase 3 | ||
| Cat No | Product Name / Activity | Date Added |
| 6092 | TDZD 8 | Mar 2017 |
| Selective non-ATP competitive inhibitor of GSK 3β | ||
GPR171 | ||
| Cat No | Product Name / Activity | Date Added |
| 6306 | BigLEN (rat) | Jul 2017 |
| Potent GPR171 agonist | ||
| 6304 | BigLEN (mouse) | Jul 2017 |
| GPR171 agonist | ||
| 6299 | MS 15203 | Aug 2017 |
| Potent and selective GPR171 partial agonist | ||
GTPases | ||
| Cat No | Product Name / Activity | Date Added |
| 5986 | NAV 2729 | Feb 2017 |
| Selective ARF6 inhibitor | ||
Heme Oxygenase | ||
| Cat No | Product Name / Activity | Date Added |
| 6119 | OB 24 hydrochloride | Aug 2017 |
| Potent and selective heme oxygenase 1 (HO-1) inhibitor | ||
Hexokinases | ||
| Cat No | Product Name / Activity | Date Added |
| 6049 | PF 04937319 | Aug 2017 |
| Glucokinase partial activator | ||
Histone Acetyltransferases | ||
| Cat No | Product Name / Activity | Date Added |
| 5103 | Lys-CoA | Jun 2017 |
| Selective p300 inhibitor | ||
Histone Deacetylases | ||
| Cat No | Product Name / Activity | Date Added |
| 6208 | MS 275 | Jun 2017 |
| HDAC (Class I) inhibitor | ||
| 6270 | Tubastatin A hydrochloride | Jun 2017 |
| Potent HDAC6 inhibitor | ||
| 6284 | BRD 73954 | Jun 2017 |
| Dual histone deacetylase (HDAC) 6/8 inhibitor | ||
Histone Peptides | ||
| Cat No | Product Name / Activity | Date Added |
| 6215 | H3K4(Me2) (1-20) | May 2017 |
| Histone H3 peptide | ||
IκB Kinase | ||
| Cat No | Product Name / Activity | Date Added |
| 5300 | BI 605906 | Mar 2017 |
| Selective IKKβ inhibitor | ||
| 5672 | GSK 319347A | Feb 2017 |
| Potent and selective IKKε inhibitor | ||
Integrins | ||
| Cat No | Product Name / Activity | Date Added |
| 6048 | R-BC154 | Aug 2017 |
| High affinity fluorescent α4β1 /α9β1 inhibitor; mobilizes HSCs | ||
| 6047 | BOP | Mar 2017 |
| Dual α9β1/α4β1 integrin inhibitor; preferentially mobilizes HSCs | ||
Inward Rectifier Potassium (Kir) Channels | ||
| Cat No | Product Name / Activity | Date Added |
| 6086 | AMP PNP | Mar 2017 |
| Kir6 blocker; non-hydrolyzable AMP analog | ||
IRE1 | ||
| Cat No | Product Name / Activity | Date Added |
| 6009 | B I09 | Apr 2017 |
| IRE1 endonuclease inhibitor; cell permeable | ||
JAK Kinase | ||
| Cat No | Product Name / Activity | Date Added |
| 5818 | NVP BSK 805 | Aug 2017 |
| Potent JAK2 inhibitor; orally bioavailable | ||
JNK/c-Jun | ||
| Cat No | Product Name / Activity | Date Added |
| 6258 | CC 401 dihydrochloride | May 2017 |
| High affinity JNK inhibitor; also inhibits HCMV replication | ||
LRRK2 | ||
| Cat No | Product Name / Activity | Date Added |
| 6289 | JH-II-127 | Aug 2017 |
| Potent and selective LRRK2 inhibitor | ||
LXR-like Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6138 | SR 9243 | Mar 2017 |
| Selective LXR inverse agonist | ||
Lysine Methyltransferases | ||
| Cat No | Product Name / Activity | Date Added |
| 4930 | UNC 2399 | Jun 2017 |
| Biotinylated UNC 1999 (Cat.No. 4904) | ||
| 6128 | GSK 343 | Jun 2017 |
| Potent and selective SAM-competitive EZH2 inhibitor | ||
| 6282 | BRD 4770 | Jun 2017 |
| G9a inhibitor and S-adenosyl methionine mimetic; cell permeable | ||
| 6167 | A 196 | Jul 2017 |
| Potent and selective SUV420H1/H2 inhibitor | ||
Matrix Metalloproteases | ||
| Cat No | Product Name / Activity | Date Added |
| 6088 | SB 3CT | Feb 2017 |
| Selective high affinity MMP2 inhibitor | ||
Miscellaneous Glutamate | ||
| Cat No | Product Name / Activity | Date Added |
| 5785 | MDNI-caged-L-glutamate | Feb 2017 |
| Stable photoreleaser of L-glutamate | ||
Monocarboxylate Transporters | ||
| Cat No | Product Name / Activity | Date Added |
| 5658 | AR-C 141990 hydrochloride | Jul 2017 |
| MCT1 inhibitor | ||
mTOR | ||
| Cat No | Product Name / Activity | Date Added |
| 6188 | Everolimus | Apr 2017 |
| mTOR inhibitor;immunosuppressant | ||
Na+/Ca2+ Exchanger | ||
| Cat No | Product Name / Activity | Date Added |
| 6164 | SEA 0400 | Apr 2017 |
| Potent Na+/Ca2+ exchanger (NCX) inhibitor. | ||
Nek2 Kinase | ||
| Cat No | Product Name / Activity | Date Added |
| 4322 | JH 295 | May 2017 |
| Irreversible Nek2 inhibitor | ||
| 5150 | NCL 00017509 | May 2017 |
| Potent and reversible NIMA related kinase 2 (Nek2) inhibitor | ||
NF-κB and IκB | ||
| Cat No | Product Name / Activity | Date Added |
| 5846 | IT 901 | Feb 2017 |
| NF-κB c-Rel subunit inhibitor | ||
| 6259 | RAGE antagonist peptide | May 2017 |
| Receptor for advanced glycation end products (RAGE) antagonist | ||
Nicotinic (α4β2) Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 5963 | CMPI hydrochloride | May 2017 |
| Potent positive allosteric modulator of α4β2 nAChRs; also inhibitor of (α4)2(β2)3, muscle-type and Torpedo nAChRs | ||
Non-selective CCK | ||
| Cat No | Product Name / Activity | Date Added |
| 6264 | Caerulein | Mar 2017 |
| CCK agonist | ||
Non-selective Endothelin | ||
| Cat No | Product Name / Activity | Date Added |
| 6232 | Bosentan | Mar 2017 |
| High affinity dual ETA and ETB receptor antagonist;orally bioavailable | ||
NPY Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6288 | Peptide YY (3-36) human | Jun 2017 |
| NPY Y2 receptor agonist | ||
Orphan 7-TM Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6277 | 7α,25-Dihydroxycholesterol | Jun 2017 |
| Highly potent GPR183 (EBI2) agonist | ||
Other Dehydrogenases | ||
| Cat No | Product Name / Activity | Date Added |
| 6196 | Brequinar sodium | Aug 2017 |
| Potent and selective dihydroorotate dehydrogenase (DHODH) inhibitor | ||
Other Hydrolases | ||
| Cat No | Product Name / Activity | Date Added |
| 5865 | KLH 45 | Mar 2017 |
| Potent DDHD2 inhibitor | ||
| 6098 | Lalistat 1 | Aug 2017 |
| Potent and selective lysosomal acid lipase (LAL) inhibitor | ||
Other Kinases | ||
| Cat No | Product Name / Activity | Date Added |
| 6036 | STK16-IN-1 | May 2017 |
| Serine/threonine protein kinase 16 (STK16) inhibitor; also inhibits PI 3Kδ, PI 3Kγ and mTOR kinases. | ||
Other Lipid Metabolism | ||
| Cat No | Product Name / Activity | Date Added |
| 5850 | HM 50316 | Feb 2017 |
| High affinity FABP4 inhibitor | ||
Other Lyases | ||
| Cat No | Product Name / Activity | Date Added |
| 6101 | SHIP 2a | Feb 2017 |
| Cystathione γ lyase (CSE) inhibitor | ||
Other Nuclear Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 5821 | C-DIM 12 | May 2017 |
| Nurr1 activator; inhibits NF-κB-dependent gene expression | ||
Other Proteases | ||
| Cat No | Product Name / Activity | Date Added |
| 6194 | TM 5441 | Jun 2017 |
| Plasminogen activator inhibitor-1 (PAI-1) inhibitor | ||
Other Reductases | ||
| Cat No | Product Name / Activity | Date Added |
| 5842 | MK 386 | May 2017 |
| Potent, selective human type 1 5α-reductase inhibitor | ||
| 5921 | D9 | May 2017 |
| Potent thioredoxin reductase (TrxR) inhibitor | ||
| 6189 | Myricetin | Jun 2017 |
| Irreversible TrxR inhibitor | ||
p97 ATPase | ||
| Cat No | Product Name / Activity | Date Added |
| 6180 | NMS 873 | Apr 2017 |
| Potent and selective p97 ATPase (VCP) allosteric inhibitor | ||
Parathyroid Hormone Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6303 | Parathyroid hormone (1-34) (bovine) | Jun 2017 |
| Parathyroid hormone (PTH) receptor agonist. | ||
| 6301 | Parathyroid hormone (1-34) (rat) | Jun 2017 |
| Parathyroid hormone (PTH) receptor agonist | ||
PFKFB3 | ||
| Cat No | Product Name / Activity | Date Added |
| 5675 | AZ PFKFB3 26 | May 2017 |
| Potent and selective PFKFB3 inhibitor | ||
Phosphodiesterases | ||
| Cat No | Product Name / Activity | Date Added |
| 6311 | Tadalafil | May 2017 |
| Potent and highly selective PDE5 inhibitor; orally bioavailable | ||
Poly(ADP-ribose) Polymerase | ||
| Cat No | Product Name / Activity | Date Added |
| 6060 | AZD 2461 | May 2017 |
| Potent PARP inhibitor; orally bioavailable | ||
| 6230 | Rucaparib camsylate | Aug 2017 |
| PARP inhibitor | ||
Progesterone Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6285 | Megestrol Acetate | May 2017 |
| Synthetic progesterone analog | ||
Protein Kinase A | ||
| Cat No | Product Name / Activity | Date Added |
| 6287 | st-Ht31 P | Jul 2017 |
| Negative control for st-Ht31 (Cat. No. 6286) | ||
| 6286 | st-Ht31 | Jul 2017 |
| Inhibits PKA/AKAP interactions; cell permeable | ||
| 6221 | PKI (5-24) | Mar 2017 |
| High affinity PKA inhibitor | ||
Protein Kinase C | ||
| Cat No | Product Name / Activity | Date Added |
| 5343 | TPPB | May 2017 |
| High affinity PKC activator; also APP modulator | ||
Protein Prenyltransferases | ||
| Cat No | Product Name / Activity | Date Added |
| 6265 | Lonafarnib | Jul 2017 |
| Potent farnesyl transferase inhibitor | ||
Purinergic (P2Y) Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 5720 | AR-C 69931 tetrasodium salt | Mar 2017 |
| Highly potent P2Y12 antagonist | ||
| 6078 | BPTU | Jul 2017 |
| P2Y1 allosteric antagonist | ||
| 6317 | Prasugrel | Jul 2017 |
| Irreversible P2Y12 antagonist; antiplatelet and orally active | ||
Retinoic Acid Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 5758 | AGN 193109 | Mar 2017 |
| High affinity pan-RAR antagonist | ||
Retinoic Acid-related Orphan Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 5987 | (±)-ML 209 | Apr 2017 |
| RORγt inverse agonist; suppresses Th17 cell differentiation | ||
Rev-Erb Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6038 | SR 10067 | Aug 2017 |
| Selective Rev-Erbα/β agonist; anxiolytic | ||
RNA/DNA Polymerase | ||
| Cat No | Product Name / Activity | Date Added |
| 6234 | Entecavir | Apr 2017 |
| Potent and selective hepatitis B virus inhibitor | ||
Sphingosine Kinase | ||
| Cat No | Product Name / Activity | Date Added |
| 5452 | SKI 178 | May 2017 |
| Non-lipid sphingosine kinase 1 (SphK1) inhibitor | ||
Sphingosine-1-Phosphate Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6176 | FTY 720 | Feb 2017 |
| Potent S1P receptor agonist; also immunosuppressant | ||
Src Kinases | ||
| Cat No | Product Name / Activity | Date Added |
| 6073 | P21d hydrochloride | Jun 2017 |
| Potent and selective Brk inhibitor | ||
STATs | ||
| Cat No | Product Name / Activity | Date Added |
| 6218 | Galiellalactone | Apr 2017 |
| STAT3 inhibitor; active in vivo | ||
Syk Kinase | ||
| Cat No | Product Name / Activity | Date Added |
| 6012 | OXSI 2 | May 2017 |
| Potent Syk kinase inhibitor; also inhibits assembly of NLRP3 inflammasomes | ||
TGF-β Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 6016 | IN 1130 | Jul 2017 |
| Potent and selective inhibitor of TGF-βRI | ||
Tocriscreen Compound Libraries | ||
| Cat No | Product Name / Activity | Date Added |
| 5932 | Tocriscreen Library of FDA-Approved Compounds | Mar 2017 |
| A library of 160 FDA-approved compounds (250 μL 10 mM DMSO solutions) | ||
Tocriscreen Toolboxes | ||
| Cat No | Product Name / Activity | Date Added |
| 5933 | Tocriscreen Kinase Inhibitor Toolbox I | Apr 2017 |
| A library of 80 kinase inhibitor compounds (250 μL 10 mM DMSO solutions) | ||
| 6268 | Tocriscreen Kinase Inhibitor Toolbox I & II | Apr 2017 |
| A library of 160 kinase inhibitor compounds (250 μL 10 mM DMSO solutions) | ||
| 6225 | Tocriscreen Kinase Inhibitor Toolbox II | Apr 2017 |
| A library of 80 kinase inhibitor compounds (250 μL 10 mM DMSO solutions) | ||
Toll-like Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 5705 | M62812 | Aug 2017 |
| TLR-4 inhibitor | ||
| 6191 | TH 1020 | Jul 2017 |
| Toll-like receptor (TLR) 5/Flagellin complex antagonist | ||
Ubiquitin E3 Ligases | ||
| Cat No | Product Name / Activity | Date Added |
| 6155 | cis MZ 1 | Apr 2017 |
| Negative Control for MZ1 | ||
| 6156 | VH 298 | Apr 2017 |
| High-affinity inhibitor of VHL | ||
| 6305 | Lenalidomide | Jun 2017 |
| Cereblon binder; induces ubiquitination and degradation of CK1α by E3 ubiquitin ligase | ||
| 6302 | Pomalidomide | Jun 2017 |
| Cereblon ubiquitination inhibitor; also TNFα inhibitor and antiangiogenic | ||
| 6157 | cis VH 298 | Apr 2017 |
| Negative control for VH 298 | ||
| 6154 | MZ 1 | Apr 2017 |
| (+)-JQ1 based PROTAC that selectively degrades BRD4 in cells | ||
Vasopressin Receptors | ||
| Cat No | Product Name / Activity | Date Added |
| 5729 | TASP 0390325 | Apr 2017 |
| Potent and selective V1B receptor antagonist; orally bioavailable | ||
Voltage-gated Potassium (KV) Channels | ||
| Cat No | Product Name / Activity | Date Added |
| 6233 | Retigabine | Mar 2017 |
| KV7 channel activator | ||